Journal
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Volume 53, Issue 3, Pages 241-252Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.critrevonc.2004.10.004
Keywords
temozolomide; chemotherapy; schedule
Categories
Ask authors/readers for more resources
This review examines the current evidence for the use of temozolomide in the treatment of solid tumours. The possible molecular and clinical advantages of temozolomide are identified and the molecular mechanism of temozolomide resistance is explored. Attempts to maximise efficacy have led to manipulation of both dosage and drug scheduling and the evidence for the various strategies is reviewed. Finally, the potential role of combination therapy is considered. (c) 2004 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available